Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01430325 · ClinicalTrials.gov registry record · NA
Test of Chamber Pressure to Divers and Chamber Attendants
A NA study, sponsored by Intermountain Health Care.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT01430325 is a NA study that has completed, run by Intermountain Health Care. The registered enrollment target is 42 participants.
The verdict
NCT01430325, a NA study, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
SCUBA divers and chamber inside attendants will undergo a brief hyperbaric chamber excursion and will be asked to what chamber pressure they were compressed and what gas they breathed.
Interventions
- DRUG Hyperbaric Oxygen (1.5 atm abs)
- DRUG Sham Chamber Session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2011-07 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01430325
The ClinicalTrials.gov registry entry for NCT01430325 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hyperbaric Oxygen (1.5 atm abs) is the first listed.
NCT01430325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01430325 about?
NCT01430325 is a clinical study titled "Test of Chamber Pressure to Divers and Chamber Attendants". SCUBA divers and chamber inside attendants will undergo a brief hyperbaric chamber excursion and will be asked to what chamber pressure they were compressed and what gas they breathed.
What is the current status of trial NCT01430325?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2011-07. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01430325?
The interventions under investigation include: Hyperbaric Oxygen (1.5 atm abs) (DRUG), Sham Chamber Session (DRUG).
Who is sponsoring clinical trial NCT01430325?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.